6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carboxylic Acid-d3 Methyl Ester

6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carboxylic Acid-d3 Methyl Ester, also known as Cefmenoxime-d3, is a synthetic antibiotic that belongs to the cephalosporin class of drugs. It is an isotopically labeled form of Cefmenoxime, which is used in the treatment of bacterial infections. The deuterium labeling in this compound is used for pharmacokinetic studies to determine the metabolic fate of the drug in the body. Cefmenoxime-d3 works by inhibiting the synthesis of bacterial cell walls, which leads to the death of the bacteria. It is effective against a broad range of gram-positive and gram-negative bacteria, including those that are resistant to other antibiotics. It is commonly used to treat respiratory tract infections, skin and soft tissue infections, urinary tract infections, and sepsis. The chemical formula of Cefmenoxime-d3 is C17H13D3ClN2O5, and it has a molecular weight of 389.8 g/mol. It is a white powder that is soluble in water and methanol. The compound has a half-life of approximately 1-2 hours in the body, and it is primarily eliminated through the kidneys. In conclusion, Cefmenoxime-d3 is an important tool in pharmacokinetic studies for the evaluation of the metabolic fate of Cefmenoxime in the body. Its broad-spectrum antibacterial activity makes it an effective treatment option for a variety of bacterial infections.